- Home
- HSPO vs BOLD Comparison
HSPO vs BOLD Comparison
Compare HSPO & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSPO
- BOLD
- Stock Information
- Founded
- HSPO 2014
- BOLD 2018
- Country
- HSPO United States
- BOLD United States
- Employees
- HSPO N/A
- BOLD N/A
- Industry
- HSPO Blank Checks
- BOLD
- Sector
- HSPO Finance
- BOLD
- Exchange
- HSPO Nasdaq
- BOLD Nasdaq
- Market Cap
- HSPO 87.7M
- BOLD 81.0M
- IPO Year
- HSPO 2022
- BOLD 2024
- Fundamental
- Price
- HSPO $11.25
- BOLD $2.95
- Analyst Decision
- HSPO
- BOLD Strong Buy
- Analyst Count
- HSPO 0
- BOLD 3
- Target Price
- HSPO N/A
- BOLD $23.00
- AVG Volume (30 Days)
- HSPO 27.4K
- BOLD 57.8K
- Earning Date
- HSPO 01-01-0001
- BOLD 11-11-2024
- Dividend Yield
- HSPO N/A
- BOLD N/A
- EPS Growth
- HSPO N/A
- BOLD N/A
- EPS
- HSPO 0.33
- BOLD N/A
- Revenue
- HSPO N/A
- BOLD N/A
- Revenue This Year
- HSPO N/A
- BOLD N/A
- Revenue Next Year
- HSPO N/A
- BOLD N/A
- P/E Ratio
- HSPO $34.26
- BOLD N/A
- Revenue Growth
- HSPO N/A
- BOLD N/A
- 52 Week Low
- HSPO $10.60
- BOLD $2.82
- 52 Week High
- HSPO $11.25
- BOLD $15.24
- Technical
- Relative Strength Index (RSI)
- HSPO 69.42
- BOLD N/A
- Support Level
- HSPO $11.17
- BOLD N/A
- Resistance Level
- HSPO $11.25
- BOLD N/A
- Average True Range (ATR)
- HSPO 0.00
- BOLD 0.00
- MACD
- HSPO 0.00
- BOLD 0.00
- Stochastic Oscillator
- HSPO 100.00
- BOLD 0.00
About HSPO Horizon Space Acquisition I Corp.
Horizon Space Acquisition I Corp is a blank check company.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.